Loading clinical trials...
Loading clinical trials...
This is an ancillary study using samples collected in the ProBioRIS cohort (NCT06395662). The aim of the project is to highlight new biomarker candidates to assess the risk of conversion to clinically...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Centre Hospitalier Universitaire de Nīmes
NCT03258567 · Epstein-Barr Virus Infections, Lymphoma, and more
NCT03266653 · Epstein-Barr Virus Infections, Primary Immune Deficiency Disorder
NCT05776511 · Multiple Sclerosis, Radiologically Isolated Syndrome, and more
NCT05388331 · Multiple Sclerosis, Radiologically Isolated Syndrome
NCT06027879 · Adenovirus, Cytomegalovirus Infections, and more
CHU de Nîmes
Nîmes
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions